baber/WOPTO huggingface dataset:
Patent AU-2004218560-B2 (AU)
Title: Pseudo body odor composition and perfume composition for inhibiting body odor
Inventor: HIRANO KOJI
IPC: A61Q15/00
Filed: 2004-02-26
Granted: 2009-04-02
Abstract: The invention relates to a deodorant perfume composition enabled to mask an acid odor, said odor comprising one or more components selected from hydroxyalkynyl carboxylic acids having 5 to 8 carbon atoms and alkenyl carboxylic acids having 5 to 8 carbon atoms and one double bond comprising: (I) at least one kind or more selected from compounds or essential oils of which aroma is excellent in both of the masking and harmonizing effects to the acid odor; and at least one kind or more selected from compounds or essential oils of which aroma is excellent in the masking effect but neutral in the harmonizing effect to the acid odor. The application likewise refers to a deodorant composition and an external preparation composition, comprising the deodorant perfume composition and a method of inhibiting the acid body odor, by application of (A) at least one kind or more selected from compounds or essential oils that are excellent in both of masking and harmonizing effects; (B) at least one kind or more selected from compounds or essential oils that are excellent in the masking effect but neutral in the harmonizing effect (C) as needs arise, at least one kind or more selected from compounds or essential oils that exhibit neither the masking effect nor the harmonizing effect.
Patent AU-2004270103-B2 (AU)
Title: Human monoclonal antibodies against Bacillusanthracis protective antigen
Inventor: KELER TIBOR
IPC: C12Q1/68
Filed: 2004-05-21
Granted: 2012-02-23
Abstract: Isolated human monoclonal antibodies which bind to Anthrax protective antigen 035 disclosed. The human antibodies can be produced in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. A1so disclosed are derivatives of the human antibodies (e.g., bispecific antibodies and immunoconjugates), pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Patent AU-2006285220-B2 (AU)
Title: Ultraviolet light treatment chamber
Inventor: COOPER JAMES RANDALL
IPC: G01N21/00
Filed: 2006-08-11
Granted: 2012-11-08
Abstract: This invention relates generally to methods and apparatuses for the treatment of liquids and gases using ultraviolet light. In one embodiment, a substantially enclosed chamber coated with a reflective material containing an ultraviolet lamp and an ultraviolet transmissive tube running through the chamber for the treatment of liquid passed therethrough is disclosed.
Patent AU-2007201313-B2 (AU)
Title: Surgical suturing apparatus with needle release system
Inventor: STOKES MICHAEL J
IPC: A61B17/062
Filed: 2007-03-27
Granted: 2012-08-30
Abstract: A surgical suturing apparatus includes a suture housing, a needle mounted within the suture housing for movement about an arcuate path, and a drive assembly operably associated with the needle for controlling movement of the needle with a suture secured thereto about the arcuate path in a manner facilitating application of the suture to tissue. The suture housing has an open position and a closed position, and the needle can be removed from the suture housing when in the open position.
Patent AU-2007210030-B2 (AU)
Title: Apparatus and method for tissue closure
Inventor: EDWARDS BRIAN R
IPC: A61B17/06
Filed: 2007-01-29
Granted: 2013-09-26
Abstract: A tissue closure device includes a pusher assembly having a drive arm extending from a drive shaft and a drive mechanism at a distal end of the drive arm, wherein the drive mechanism is capable of releasably engaging and rotating a suturing needle having a pointed end and a blunt end about a rotational axis and a cartridge having a protective housing and the suturing needle, the cartridge extending from a distal end of a cartridge holder assembly and releasably attached to the cartridge holder assembly. A pointed end of the suturing needle may be positioned within the protective housing before and after a complete rotation of the suturing needle about the rotational axis. A removable electronic module may be provided controlled by an actuator that mechanically engages the drive shaft to rotate the drive shaft and the drive mechanism, thereby rotating the suturing needle about the rotational axis.
Patent AU-2007214128-B2 (AU)
Title: Use of KCNQ-openers for treating or reducing the symptoms of schizophrenia
Inventor: RITZEN ANDREAS
IPC: A61K31/506
Filed: 2007-02-02
Granted: 2012-05-17
Abstract: The invention relates to a novel method for treating or reducing the symptoms of schizophrenia, said method comprising administering to a host in need thereof an effective amount of a compound able to selectively increase the ion flow through KCNQ potassium channels. Furthermore the invention relates to the use of selective KCNQ potassium channel openers for the preparation of a pharmaceutical composition for treating or reducing the symtoms of schizophrenia and related symptoms, disorders and diseases. Furthermore the invention relates to a method of screening for a compound, which is a selective KCNQ potassium channel opener and which is capable of having an anti-psychotic potential.
Patent AU-2007219351-B2 (AU)
Title: Elevator system with safety device on elevator doors
Inventor: KOCHER HANS
IPC: B66B13/28
Filed: 2007-09-27
Granted: 2013-03-14
Abstract: Abstract In an elevator system that comprises an elevator hoistway 5 (101), a plurality of hoistway doors (203.1, 203.2) arranged above each other each with at least one horizontally moveable hoistway door panel (209.1, 209.2), and an elevator car (205) with a car door (206) that has at least one horizontally movable car door panel (207), fastened to the 10 car door panel (207) is a vertically extending barrier rail (208), and in each of the areas lying in vertical direction between the hoistway door panels (209.1, 209.2) of adjacent hoistway doors (203.1, 203.2) two locationally fixed stopping dogs (210) that are vertically spaced from each 15 other are arranged in such manner that in each case one of the stopping dogs (210) limits the opening movement of the barrier rail (208), and thereby of the car door panel (207), when the position of the elevator car (205) deviates in upward direction or in downward direction by a certain 20 minimum distance from the intended stopping position. (Fig. 2)
Patent AU-2007242695-B2 (AU)
Title: Method for optimising the power supply to a linear transmitting aerial towed so as to transmit in omnidirectional mode
Inventor: YVES DOISY
IPC: G01S7/521
Filed: 2007-04-26
Granted: 2011-10-13
Abstract: The invention relates to sonar transmission means and in particular to transmission means that enable the implementation of an omnidirectional acoustic transmission. The invention relates to a method for implementing an omnidirectional transmission using a towed linear aerial of length L greater than the wave length of the output signal, constituted by a plurality of P projectors, with the space between projectors being substantially less than /2. The inventive method consists mainly in applying to each projector an output signal emanating from a common output signal, said common signal being assigned a delay expressed in accordance with a law that comprises a non-linear term dependent on the position of the projector in the aerial, the application of said law enabling the sendout chart angular aperture to be modulated. The invention enables in particular the implementation of sonar detection systems that comprise transmitting and receiving aerials of substantially identical diameter which can be wound onto one and the same winch without it being necessary to separate them.
Patent AU-2007262265-B2 (AU)
Title: Skin external preparation containing triterpenic acid
Inventor: AKAMATSU HISASHI
IPC: A61P17/10
Filed: 2007-04-24
Granted: 2012-06-07
Abstract: Disclosed is a preparation for external application to skin, which contains a triterpenic acid typified by ursolic acid and the like. For obtaining a preparation for external application to skin having excellent storage stability by improving the dissolution stability of the triterpenic acid and the like, 4-alkylresorcinol such as 4-n-butylresorcinol is added into a preparation for external application to skin containing a triterpenic acid such as ursolic acid and the like.
Patent AU-2007262635-B2 (AU)
Title: Polynucleotides and polypeptide sequences involved in cancer
Inventor: TREMBLAY GILLES BERNARD
IPC: A61K38/17
Filed: 2007-06-22
Granted: 2014-09-11
Abstract: The present invention relates to polynucleotide and polypeptide sequences which are differentially expressed in cancer cells compared to normal cells. The present invention more particularly relates to the use of these sequences in the diagnosis, prognosis or treatment of cancer and in the detection of cancer cells.
Patent AU-2007266338-B2 (AU)
Title: Elongate strip assembly
Inventor: WOOLSTON GEOFF
IPC: E04H17/00
Filed: 2007-05-30
Granted: 2013-05-23
Abstract: The present invention provides a two part assembly for an elongate strip such as a slat, for use in slatting or latticework. The assembly comprises a base member, to be fastened to a support by a fastening means (such as a rivet), and a cover member to hide the fastening means from view. This improves the appearance of the resulting structure. It also provides other advantages such as in the maintenance of the structure.
Patent AU-2007346587-B2 (AU)
Title: Methods for the treatment of Senile Dementia of the Alzheimer's Type
Inventor: GOODENOWE DAYAN
IPC: A61K31/232
Filed: 2007-08-27
Granted: 2014-03-27
Abstract: The present invention relates to the diagnosis, risk assessment, prevention, and treatment of Senile Dementia of the Alzheimer's Type (SDAT). More specifically the present invention relates to the measurement of ethanolamine phospholipids in human serum. Subsets of these molecules are significantly altered in subjects with pathologically confirmed deposits of β-amyloid versus subjects without β-amyloid deposits and in subjects with a clinical manifestation of dementia consistent with a diagnosis of SDAT versus non-demented controls. Further, the invention relates to the diagnosis of various stages of SDAT, the early detection and prevention of SDAT symptoms, the treatment of SDAT, the differential diagnosis of non-SDAT dementia, and the identification of molecular targets for which chemical or biological treatments can be designed for the therapeutic intervention of SDAT. The present invention also relates to methods of using a molecular diagnostic assay to direct and select the appropriate therapeutic intervention for subjects suffering from dementia. The present invention also relates to small molecules or metabolites that are found to have significantly different abundances between persons with a clinical manifestation of SDAT and normal, non-demented patients.
Patent AU-2007357741-B2 (AU)
Title: Granule coated with urethane resin
Inventor: WATANABE ATSUSHI
IPC: C05G3/00
Filed: 2007-08-13
Granted: 2012-09-13
Abstract: A coated granule obtained by coating a bioactive substance-containing granule with a urethane resin obtained by reaction of an aromatic polyisocyanate with an alcohol mixture comprising a polyesterpolyol having 15 wt% or more of an oxycarbonyl structure (-O-C(=O)-) part in the molecule and a C4-C30 alkanol optionally substituted by one or more aryl groups, wherein the molar ratio of the polyesterpolyol to the alkanol is 1:1 to 100:1, is capable of controlling elution of the bioactive substance appropriately, and, the urethane resin forming the coat film shows degradability in soil.
Patent AU-2008201630-B2 (AU)
Title: Powered surgical stapling device platform
Inventor: ZEMLOK MICHAEL
IPC: A61B17/064
Filed: 2008-04-11
Granted: 2013-12-19
Abstract: POWERED SURGICAL STAPLING DEVICE PLATFORM Abstract The present disclosure provides for a surgical instrument (100) which includes a housing (110) and an endoscopic portion (140) extending distally from the housing and s defining a first longitudinal axis. The surgical instrument (100) also includes an end effector (160) disposed adjacent a distal portion (142) of the endoscopic portion (160). The end effector (160) includes an anvil assembly (302) and a cartridge assembly (300). The anvil assembly (302) is pivotally coupled to the cartridge assembly (300) to be movable from a first actuation position to at least one other second actuation position. 10 The surgical instrument (100) further includes a firing rod (402) having a shaft (404) defining a second longitudinal axis, the shaft (404) having a cam member which is in mechanical cooperation with the anvil assembly (302) and is configured to move the anvil assembly (302) from the first actuation position to the at least one other second actuation position upon rotation of the firing rod about the second longitudinal axis. asO -~ *-- - L Co~
Patent AU-2008213905-B2 (AU)
Title: Wireless network communications system
Inventor: QUICK ASHLEIGH GLEN
IPC: H04L47/32
Filed: 2008-02-06
Granted: 2014-01-16
Abstract: Disclosed are a method, system and protocol for processing a Transmission within a wireless network, the network including at least one device that transmits the Transmission and at least one device that receives the Transmission. The method provides for receiving the Transmission at the device that receives the Transmission; determining whether the device that receives the Transmission has previously received the Transmission; and actioning the received Transmission only if the device that receives the transmission has not previously received the Transmission.
Patent AU-2008216371-B2 (AU)
Title: Joint revision implant
Inventor: EINHORN THOMAS
IPC: A61F2/30
Filed: 2008-02-11
Granted: 2014-04-10
Abstract: An osteoconductive backing implant for joint revisions is provided that may enhance bone healing and, for cementless implants, bony integration of the implant. The backing implant comprises a generally planar surface that may be formed into a generally hemispherical shape. In one embodiment, the backing implant comprises a disc having an inner hole and an outer edge, at least one slit extending from the inner hole to the outer edge. The disc may be formed from a coherent mass of elongate, mechanically entangled demineralized bone particles.
Patent AU-2008227516-B2 (AU)
Title: Arsenic-containing solid and method for producing it
Inventor: KUBO HISASHI
IPC: C01G49/00
Filed: 2008-03-13
Granted: 2013-01-10
Abstract: Disclosed is an arsenic-containing solid material comprising 100 parts by mass of a scorodite-type iron-arsenic compound and 1 part by mass or more of an iron oxidation compound, wherein the scorodite-type iron-arsenic compound is synthesized by adding an oxidizing agent to an acidic aqueous solution containing a pentavalent arsenic ion and a bivalent arsenic ion to cause the precipitation of the iron-arsenic compound to proceed while agitating the solution, and terminating the precipitation at a pH value of 1.2 or lower. The iron oxidation compound may be goethite, hematite, or a mixture thereof. It is preferred to use an iron oxidation compound having a BET specific surface area of 3 m
Patent AU-2008266742-B2 (AU)
Title: Use of benzyladenine to improve emergence of seeds treated with abscisic acid
Inventor: WILSON DALE O
IPC: A01H5/00
Filed: 2008-06-20
Granted: 2013-10-24
Abstract: This invention relates to the use of N6-phenylmethyl-l H-purin-6-amine (benzyladenine) in combination with S-(+)-abscisic acid (ABA), ABA analogs or derivatives to improve the performance of germination delay seed treatments.
Patent AU-2008302367-B2 (AU)
Title: Self-actuating signal producing detection devices and methods
Inventor: LABGOLD MARC ROBERT
IPC: C12Q1/26
Filed: 2008-09-17
Granted: 2013-10-03
Abstract: An assay system is provided of great sensitivity and portability where the presence of a specific target in a sample, as well as its concentration (qualification and quantification) is detected by reason of a potential or voltage in a closed circuit, built up a redox reaction. The reaction is produced by binding a capture moiety to an enzymatic redox reaction partner, allowing the capture moiety to bind to any target in the sample, and washing any such bound target. The bound target, if not immobilized, may be immobilized through use of a second capture moiety. Substrate for the enzyme is then added. The action of the enzyme upon the substrate frees electrons, creating a potential across an anode and cathode which may be separated by a membrane.
Patent AU-2008304201-B2 (AU)
Title: Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression
Inventor: REED THOMAS
IPC: C12N15/87
Filed: 2008-09-26
Granted: 2014-08-14
Abstract: The present invention provides synthetic 5'UTRs comprising a first polynucleotide fragment and a second polynucleotide fragment, wherein the first polynucleotide fragment comprises at least one splice site of a first eukaryotic gene, the second polynucleotide fragment comprises at least a portion of 5' untranslated region of a second eukaryotic gene, and the first polynucleotide fragment is located 5' of the second polynucleotide fragment. In one embodiment, the first polynucleotide fragment comprises the second intron of a sarcoplasmic/endoplasmic reticulum calcium ATPase gene and the second polynucleotide fragment comprises at least a portion of the 5' untranslated region (5'UTR) of a eukaryotic casein gene. The synthetic 5'UTRs are useful for increasing the expression of a transgene when positioned between a promoter and a transgene within an expression vector. The present invention also provides vectors comprising synthetic 5'UTRs and methods for increasing the expression of a transgene using synthetic 5'UTRs.
Patent AU-2008310263-B2 (AU)
Title: Modulation of SIRPALPHA - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
Inventor: PRASOLAVA TATIANA
IPC: A61K38/17
Filed: 2008-10-10
Granted: 2014-09-11
Abstract: The invention relates to modulating the SIRPα - CD47 interaction in order to increase hematopoietic stem cell engraftment and compounds therefor. In some embodiments, there is provided isolated SIRPα and CD47 polypeptides, fragments and fusion proteins for enhancing hematopoietic stem cell engraftment. Further there is provided methods for increasing hematopoietic stem cell engraftment through administration of the above polypeptides.
Patent AU-2008313543-B2 (AU)
Title: Couplers and vehicles provided with couplers
Inventor: MONAGHAN CONOR
IPC: A01B59/06
Filed: 2008-10-15
Granted: 2015-06-25
Abstract: The present invention provides a coupler (201), use of the coupler (201), and a utility vehicle having the coupler (201), the coupler (201) having a body portion and a linearly movable rail (235), arranged to be moved by an actuator, the body portion comprising an open jaw (207) arranged to receive a mounting formation of a tool, the rail having a first position in which the rail (235) is retracted relative to the open jaw (207) and in which a mounting formation can enter a recess defined by the jaw (207), and an advanced position in which the rail (235) restricts the opening to the jaw (207), thereby arranged to trap, in use, the mounting formation in the recess.
Patent AU-2008321669-B2 (AU)
Title: Nut for self-tapping sheet metal screws
Inventor: WONG CHIANG HENG
IPC: F16B35/04
Filed: 2008-09-03
Granted: 2012-01-19
Abstract: A nut for use with self-tapping screws (3) utilized in sheet metal work which comprises an elongated hexagonal-shaped body (1) with a straight through centre core (4) and has a flanged rear end (7) that is beveled (9) at the edge of the bore to assist in seating and proper alignment.
Patent AU-2008327932-B2 (AU)
Title: Compositions for reducing oxidative stress and uses thereof
Inventor: BOHM MARKUS
IPC: A61Q19/00
Filed: 2008-11-19
Granted: 2012-05-31
Abstract: The present invention relates to the use of one or more tripeptides selected from the group consisting of Lys-Pro-Val, Lys-Pro-Thrand pGlu-His-Pro for the reduction of oxidative stress. The above tripeptides are particularly useful for the treatment of a disease or damage caused by oxidative stress; such as vitiligo, scleroderma, necrosis, or erythema; furthermore, a disease or damage of the hair, like premature hair loss or premature formation of grey hair. Furthermore the invention relates the cosmetic use of the above tripeptides, in particular against skin aging. Further the invention relates cosmetic compositions containing at least one of said tripeptides.
Patent AU-2008329327-B2 (AU)
Title: LNA antagonists targeting the androgen receptor
Inventor: WORM JESPER
IPC: C12N15/113
Filed: 2008-11-26
Granted: 2015-07-16
Abstract: The present invention relates to oligomer compounds (oligomers), which target the androgen receptor mRNA in a cell, leading to reduced expression of the androgen receptor. Reduction of the androgen receptor expression is beneficial for the treatment of certain medical disorders, such as a disease or a medical disorder as disclosed herein, such as a hyperproliferative disorder, such as cancer.
Patent AU-2008348311-B2 (AU)
Title: Adhesive complex coacervates and methods of making and using thereof
Inventor: STEWART RUSSELL JOHN
IPC: C11D17/00
Filed: 2008-11-13
Granted: 2014-06-26
Abstract: Described herein is the synthesis of adhesive complex coacervates. The adhesive complex coacervates are composed of a mixture of one or more polycations, one or more poly anions, and one of more multivalent cations. The polycations and polyanions in the adhesice complex coacervate are crosslinked with one another by covalent bonds upon curing. The adhesive complex coacervates have several desirable features when compared to conventional bioadhesives, which are effective in water-based applicatgions. The adhesive complex coacervates described herein exhibit good interfacial tension in water when applied to a substrate (i.e., they spread over the interface rather than being beaded up). Additionally, the ability of the complex coacervate to crosslink intermolecularly increases the cohesive strength of the adhesive complex coacervate. The adhesive complex coacervates have numerous biological applications as bioadhesives and drug delivery devices. In particular, the adhesive complex coacervates described herein are particularly useful in underwater applications and situations where water is present such as, for example, physiological conditions.
Patent AU-2009200879-B2 (AU)
Title: Humidification of Respiratory Gases
Inventor: SMITH IAN MALCOLM
IPC: A61M16/16
Filed: 2009-03-05
Granted: 2014-05-15
Abstract: A humidifier (4) for a respiratory apparatus for delivering a humidified flow of breathable gas to a patient includes a humidifier chamber configured to store a supply of water to humidify the flow of breathable gas. The humidifier chamber includes a first heating element configured to heat the supply of water. The humidifier also includes a relative humidity sensor (52) to detect a relative humidity of ambient air and generate signals indicative of the ambient relative humidity; a first temperature sensor (50) to detect a temperature of ambient air and generate signals indicative of the ambient temperature; and a controller (44) configured to determine an absolute humidity of the ambient air from the signals generated by the relative humidity sensor and the first temperature sensor and to control the first heating element (46) to provide a predetermined relative humidity to the flow of breathable gas. A method of humidifying a flow of breathable gas to be provided to a patient includes determining an absolute humidity of ambient air used to form the flow of breathable gas; and controlling a temperature of a supply of water that humidifies the flow of breathable gas to provide a predetermined absolute humidity corresponding to a predetermined temperature and a predetermined relative humidity of the flow to be delivered to the patient.